Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 2, 2011, Pages 282-292

  Coakley, M ^a   Hall, J E ^a   Evans, C ^a   Duff, E ^a   Billing, V ^a   Yang, L ^a   Mcpherson, D ^a   Stephens, E ^a   Macartney, N ^a   Wilkes, A R ^a   Collins, P W ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cardiopulmonary bypass; Hemorrhage; Thrombin generation; Thromboelastometry

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; HEPARIN; PROTHROMBIN; THROMBIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; CARDIOPULMONARY BYPASS; DISEASE ASSOCIATION; ENDOGENOUS THROMBIN POTENTIAL; FEMALE; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION TESTS; CALIBRATION; CORONARY ARTERY BYPASS; HEMOSTASIS; HUMANS; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; ROC CURVE; THROMBIN;

EID: 79251563789     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.04146.x     Document Type: Article

References (30)

1. Spiess BD, McCarthy RJ, Tuman KJ, Ivankovich AD. Hemorrhage after bypass surgery. Chest 1990; 98: 255-6.
2. Despotis G, Avidan M, Eby C. Prediction and management of bleeding in cardiac surgery. J Thromb Haemost 2009; 7 (Suppl 1): 111-7.
3. Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 1996; 111: 1037-46.
4. Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg 2004; 78: 527-34.
5. Wells AW, Mounter PJ, Chapman CE, Stainsby D, Wallis JP. Where does blood go? Prospective observational study of red cell transfusion in North England Br Med J 2002; 325: 803.
6. Bevan DH. Cardiac bypass haemostasis: putting blood through the mill. Br J Haematol 1999; 104: 208-19.
7. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76: 1680-97.
8. Roberts HR, Monroe DM, Escobar MA. Current concepts of hemostasis: implications for therapy. Anesthesiology 2004; 100: 722-30.
9. Wachtfogel YT, Harpel PC, Edmunds LH Jr, Colman RW. Formation of C1s-C1-inhibitor, kalikrein-C1-inhibitor, and plasmin-alpha2 -plasmin-inhibitor complexes during cardiopulmonary bypass. Blood 1989; 73: 468-71.
10. Gelb AB, Roth RI, Levin J, London M, Noall RA, Houck NW, Cloutier M, Verrier E, Mangano DT. Changes in blood coagulation during and following cardiopulmonary bypass. Am J Clin Pathol 1996; 106: 87-99.
11. Gravlee GP, Arora S, Lavender SW, Mills SA, Hudspeth AS, Cordell AR, James RL, Brockschmidt JK, Stuart JJ. Predictive value of blood clotting tests in cardiac surgical patients. Ann Thorac Surg 1994; 58: 216-21.
12. Chee YL, Crawford JC, Watson HG, Greaves M. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. Br J Haematol 2008; 140: 496-504.
13. Kang YG, Martin DJ, Marquez J, Lewis JH, Bontempo FA, Shaw BW Jr, Starzl TE, Winter PM. Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Anesth Analg 1985; 64: 888-96.
14. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography- guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88: 312-9.
15. Tuman KJ, Spiess BD, McCarthy RJ, Ivankovich AD. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg 1989; 69: 69-75.
16. Essell JH, Martin TJ, Salinas J, Thompson JM, Smith VC. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993; 7: 410-5.
17. Welsby IJ, Jiao K, Ortel TL, Brudney CS, Roche AM, Bennett-Guerrero E, Gan TJ. The kaolin-activated Thrombelastograph predicts bleeding after cardiac surgery. J Cardiothorac Vasc Anesth 2006; 20: 531-5.
18. Wang JS, Lin CY, Hunt WT. Thromboelastogram fails to predict postoperative haemorrhage in cardiac patients. Ann Thorac Surg 1992; 53: 435-9.
19. Nuttall GA, Oliver WC, Ereth MH, Santrach PJ. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11: 815-23.
20. Davidson SJ, McGrowder D, Roughton M, Kelleher AA. Can ROTEM thromboelastometry predict postoperative bleeding after cardiac surgery? J Cardiothorac Vasc Anesth 2008; 22: 655-61.
21. Stover EP, Siegel LC, Parks R, Levin J. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter study of Perioperative Ischaemia Research Group. Anesthesiology 1998; 88: 327-33.
22. Karkouti K, Wijeysundera DN, Beattie WS, Callum JL. Variability and predictability of large -volume red blood cell transfusion in cardiac surgery: a multicenter study. Transfusion 2007; 47: 2081-8.
23. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
24. Stainsby D, MacLennan S, Tomas D, Issac J, Hamilton PJ; British Committee for Standardisation in Haematology. Guidelines on the management of massive blood loss. Br J Haematol 2006;135: 634-41.
25. Association of Anaesthetists of Great Britain and Ireland. Blood Transfusion and the Anaesthetist. Blood Component Therapy. London: AAGBI, 2005.
26. American Society of Anesthesiologists Task Force. Practice guidelines for perioperative blood transfusions and adjuvant therapies. Anesthesiology 2006; 105: 198-208.
27. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sørensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008; 101: 769-73.
28. Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009; 120: 21-7.
29. Hsia CC, Chin-Yee IH, McAlister VC. Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. Ann Surg 2008; 248: 61-8.
30. van Veen JJ, Gatt A, Makris M. Thrombin generation testing in routine clinical practice: are we there yet? Br J Haematol 2008; 142: 889-903.